Cargando…

Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer?

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Faxon, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251195/ https://www.ncbi.nlm.nih.gov/pubmed/32479567 http://dx.doi.org/10.1016/j.jacbts.2020.03.012

Ejemplares similares

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
por: Al-Rubaish, Abdullah M., et al.
Publicado: (2020)

Antiplatelet therapy following TAVI: time to randomise
por: Delewi, R., et al.
Publicado: (2014)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence
por: Liga, Riccardo, et al.
Publicado: (2021)

Cardiac magnetic resonance imaging in primary PCI: additional value?
por: van der Wall, E. E., et al.
Publicado: (2009)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Answer to the question page 508
Publicado: (2012)

Answer to the question from page 469
Publicado: (2013)

Answer to the question from page 356
Publicado: (2013)

Answer to the question from page 117
Publicado: (2013)

Answer to the question from page 235
Publicado: (2013)

Answer to the question from page 105
Publicado: (2014)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Answer to the question 2 from page 362
Publicado: (2012)

Answer to the question 1 from page 361
Publicado: (2012)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Guo, Yong-zhe, et al.
Publicado: (2021)

β-blockers in hemodialysis: simple questions, complicated answers
por: Hundemer, Gregory L, et al.
Publicado: (2020)

Node dissection in prostate cancer: no answers for old questions
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2021)

Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing
por: Burlacu, Alexandru, et al.
Publicado: (2020)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

From theory to the bedside of the patient: it’s a long and devious way to go
por: Noyez, L.
Publicado: (2013)

Epicardial mapping and ablation of arrhythmias: is magnetic navigation the answer we have been waiting for?
por: de Groot, J. R., et al.
Publicado: (2013)

Open questions: a few that need answers in immunology
por: Stockinger, Brigitta
Publicado: (2013)

Vitamin D for COVID-19: a case to answer?
por: Martineau, Adrian R, et al.
Publicado: (2020)

Answering the call to support youth orphaned by COVID-19
por: Kentor, Rachel A, et al.
Publicado: (2021)

Genetics and tailored therapy in cardiovascular disease
por: Doevendans, P. A., et al.
Publicado: (2011)

Modeling Acute Pericarditis: An Inflammatory Step Toward Tailored Therapeutic Strategies
por: Silvestre, Jean-Sébastien
Publicado: (2021)

RAS inhibition and COVID-19: more questions than answers?
por: Kerneis, Mathieu, et al.
Publicado: (2021)

The implication of cardio-oncology on Parkinson's disease: answers begin to emerge
por: Scorza, Fulvio A., et al.
Publicado: (2022)

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
por: Christ, Günter, et al.
Publicado: (2014)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021)

COVID-19 and psychiatry: can electronic medical records provide the answers?
por: Yolken, Robert
Publicado: (2021)

Comment on Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications? Medicina 2021, 57, 357
por: Lorenzati, Bartolomeo, et al.
Publicado: (2021)

Visceral Leishmaniasis diagnosis: a rapid test is a must at the hospital bedside
por: Braz, Lucia Maria Almeida, et al.
Publicado: (2020)

Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups
por: Ford, Nathan, et al.
Publicado: (2021)

The value of Sonoclot detection technology to guide the clinical medication of the perioperative anticoagulation and antiplatelet therapy in patients with acute myocardial infarction undergoing emergent PCI
por: Yang, Wu-Xiao, et al.
Publicado: (2017)

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial
por: Shi, Xiujin, et al.
Publicado: (2021)

The answer to the question “What is the best housing temperature to translate mouse experiments to humans?” is: thermoneutrality
por: Fischer, Alexander W., et al.
Publicado: (2019)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5u9h9fh12a4thj0fq2prqja3um